SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001104659-09-057048
Filing Date
2009-09-30
Accepted
2009-09-30 16:30:33
Documents
3

Document Format Files

Seq Description Document Type Size
1 425 a09-29165_1425.htm 425 41861
2 GRAPHIC g291651dei001.jpg GRAPHIC 5368
3 GRAPHIC g291651dei002.jpg GRAPHIC 2746
  Complete submission text file 0001104659-09-057048.txt   55462
Mailing Address 400 OYSTER POINT BOULEVARD SUITE 525 SOUTH SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BOULEVARD SUITE 525 SOUTH SAN FRANCISCO CA 94080 650-266-3000
CELL GENESYS INC (Subject) CIK: 0000865231 (see all company filings)

IRS No.: 943061375 | State of Incorp.: DE | Fiscal Year End: 1017
Type: 425 | Act: 34 | File No.: 000-19986 | Film No.: 091095943
SIC: 2834 Pharmaceutical Preparations

Mailing Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069 8474780500
BIOSANTE PHARMACEUTICALS INC (Filed by) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 2836 Biological Products, (No Diagnostic Substances)